Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 9 | 2025 | 470 | 1.290 |
Why?
|
| Fluorocarbons | 2 | 2018 | 56 | 1.180 |
Why?
|
| Nanoparticles | 7 | 2025 | 231 | 1.090 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 766 | 1.080 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2024 | 3543 | 0.840 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 82 | 0.790 |
Why?
|
| Plaque, Amyloid | 3 | 2020 | 63 | 0.770 |
Why?
|
| Indans | 1 | 2021 | 53 | 0.750 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2018 | 56 | 0.750 |
Why?
|
| Liposomes | 6 | 2019 | 168 | 0.720 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 114 | 0.710 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 150 | 0.690 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 284 | 0.640 |
Why?
|
| Fluorine | 1 | 2018 | 15 | 0.630 |
Why?
|
| Amyloid | 2 | 2020 | 65 | 0.630 |
Why?
|
| Fluorine-19 Magnetic Resonance Imaging | 1 | 2018 | 4 | 0.610 |
Why?
|
| Ethers | 1 | 2018 | 6 | 0.600 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2020 | 121 | 0.540 |
Why?
|
| Blood-Brain Barrier | 2 | 2014 | 141 | 0.540 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2014 | 13 | 0.470 |
Why?
|
| Presenilin-1 | 2 | 2020 | 52 | 0.460 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 79 | 0.450 |
Why?
|
| Placenta | 3 | 2022 | 493 | 0.400 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 206 | 0.370 |
Why?
|
| Cyclohexanones | 1 | 2010 | 19 | 0.350 |
Why?
|
| Small Molecule Libraries | 1 | 2010 | 118 | 0.320 |
Why?
|
| Enterotoxins | 1 | 2009 | 82 | 0.320 |
Why?
|
| Cyclic GMP | 1 | 2009 | 92 | 0.320 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2022 | 119 | 0.310 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 567 | 0.300 |
Why?
|
| Bacterial Toxins | 1 | 2009 | 175 | 0.300 |
Why?
|
| Brain | 3 | 2024 | 2961 | 0.290 |
Why?
|
| Mice | 12 | 2025 | 17494 | 0.280 |
Why?
|
| Molecular Structure | 6 | 2021 | 285 | 0.270 |
Why?
|
| Pyrimidines | 1 | 2009 | 373 | 0.260 |
Why?
|
| Drug Design | 2 | 2021 | 146 | 0.260 |
Why?
|
| Photons | 1 | 2025 | 48 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2025 | 2056 | 0.230 |
Why?
|
| Animals | 14 | 2025 | 33749 | 0.230 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 4271 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 1683 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 2388 | 0.210 |
Why?
|
| Ligands | 2 | 2021 | 533 | 0.210 |
Why?
|
| Indocyanine Green | 1 | 2023 | 58 | 0.200 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 133 | 0.200 |
Why?
|
| Protein Aggregates | 1 | 2021 | 29 | 0.190 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 260 | 0.190 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 28 | 0.180 |
Why?
|
| Protein Folding | 1 | 2021 | 218 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 224 | 0.180 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 80 | 0.180 |
Why?
|
| Aortography | 1 | 2021 | 200 | 0.170 |
Why?
|
| Aortic Rupture | 1 | 2021 | 118 | 0.170 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 197 | 0.170 |
Why?
|
| Esters | 2 | 2009 | 29 | 0.160 |
Why?
|
| Limit of Detection | 1 | 2018 | 60 | 0.160 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 40 | 0.160 |
Why?
|
| Solubility | 1 | 2018 | 132 | 0.160 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 17 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2021 | 224 | 0.150 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 127 | 0.150 |
Why?
|
| Aorta | 1 | 2021 | 541 | 0.140 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 217 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2022 | 830 | 0.120 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 22 | 0.110 |
Why?
|
| Zingiberaceae | 2 | 2003 | 2 | 0.110 |
Why?
|
| Protein Binding | 2 | 2018 | 1741 | 0.100 |
Why?
|
| Cobalt | 2 | 2009 | 17 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2016 | 332 | 0.100 |
Why?
|
| Organophosphorus Compounds | 2 | 2009 | 22 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 143 | 0.100 |
Why?
|
| Boronic Acids | 1 | 2012 | 48 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2012 | 98 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 182 | 0.090 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2010 | 2 | 0.090 |
Why?
|
| Quinones | 1 | 2010 | 5 | 0.090 |
Why?
|
| Esterification | 1 | 2010 | 12 | 0.090 |
Why?
|
| Methane | 1 | 2010 | 12 | 0.090 |
Why?
|
| Cyclohexenes | 1 | 2010 | 10 | 0.090 |
Why?
|
| Humans | 8 | 2025 | 123169 | 0.090 |
Why?
|
| Receptors, Enterotoxin | 1 | 2009 | 1 | 0.080 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 1 | 2009 | 1 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 448 | 0.080 |
Why?
|
| Guanylate Cyclase | 1 | 2009 | 37 | 0.080 |
Why?
|
| Receptors, Peptide | 1 | 2009 | 47 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 106 | 0.080 |
Why?
|
| Enterobacter aerogenes | 1 | 2008 | 1 | 0.080 |
Why?
|
| Gadolinium | 2 | 2019 | 103 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2008 | 62 | 0.080 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 50 | 0.080 |
Why?
|
| Hippocampus | 1 | 2012 | 820 | 0.070 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 303 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1200 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4346 | 0.070 |
Why?
|
| Plants, Medicinal | 2 | 2003 | 23 | 0.070 |
Why?
|
| Pregnancy | 3 | 2022 | 7148 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2009 | 976 | 0.050 |
Why?
|
| Diarylheptanoids | 1 | 2003 | 1 | 0.050 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2003 | 5 | 0.050 |
Why?
|
| Trypanocidal Agents | 1 | 2003 | 27 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 27 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 65 | 0.050 |
Why?
|
| Adventitia | 1 | 2022 | 6 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 288 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3273 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 93 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 85 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2018 | 1070 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 189 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 178 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 161 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 382 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 80 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 530 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 207 | 0.040 |
Why?
|
| Hydrolysis | 2 | 2009 | 155 | 0.040 |
Why?
|
| Female | 4 | 2022 | 65500 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 53 | 0.040 |
Why?
|
| Catalysis | 2 | 2008 | 125 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2009 | 425 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 100 | 0.040 |
Why?
|
| Male | 3 | 2021 | 60082 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1313 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 464 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 747 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2106 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2025 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3654 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 2946 | 0.030 |
Why?
|
| Seeds | 2 | 2003 | 42 | 0.030 |
Why?
|
| Concanavalin A | 1 | 2012 | 15 | 0.020 |
Why?
|
| Dextrans | 1 | 2012 | 46 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2012 | 179 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 113 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2012 | 95 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 347 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 271 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6217 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 809 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3718 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 806 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 455 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 2008 | 9 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2008 | 15 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2008 | 82 | 0.020 |
Why?
|
| Magnetics | 1 | 2008 | 41 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 515 | 0.020 |
Why?
|
| Phosphates | 1 | 2008 | 111 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 283 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 316 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1687 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 357 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 617 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 872 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 19080 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 1291 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 16021 | 0.010 |
Why?
|
| Cameroon | 1 | 2003 | 8 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 43 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 75 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2003 | 103 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 288 | 0.010 |
Why?
|